Puneet Souda
Stock Analyst at Leerink Partners
(3.37)
# 2,324
Out of 4,417 analysts
916
Total ratings
43.8%
Success rate
2.5%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Reiterated: Buy | n/a | $127.34 | - | 67 | Jun 2, 2026 | |
| ALMR Alamar Biosciences | Initiated Coverage: Buy | $35 | $20.06 | +74.48% | 1 | May 12, 2026 | |
| TWST Twist Bioscience | Upgraded: Buy | $35 → $70 | $84.95 | -17.60% | 31 | May 5, 2026 | |
| NEO NeoGenomics | Upgraded: Buy | $14 → $25 | $10.49 | +138.32% | 50 | Apr 29, 2026 | |
| TMO Thermo Fisher Scientific | Reiterated: Buy | $500 → $580 | $472.63 | +22.72% | 50 | Oct 23, 2025 | |
| DHR Danaher | Reiterated: Buy | $235 | $181.35 | +29.58% | 18 | Oct 22, 2025 | |
| RVTY Revvity | Maintained: Buy | $115 → $110 | $101.22 | +8.67% | 14 | Sep 16, 2025 | |
| RGEN Repligen | Maintained: Buy | $200 | $131.69 | +51.87% | 42 | Sep 11, 2025 | |
| QTRX Quanterix | Maintained: Hold | $6 | $3.06 | +96.08% | 60 | Sep 10, 2025 | |
| BRKR Bruker | Maintained: Buy | n/a | $55.80 | - | 49 | Sep 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 | $128.34 | +9.09% | 39 | Sep 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $220.11 | - | 64 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $31.75 | -49.61% | 11 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $50.92 | -11.63% | 40 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.02 | +395.05% | 13 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $4.25 | +112.01% | 33 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $10 → $16 | $14.71 | +8.77% | 33 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 → $12 | $8.64 | +38.89% | 40 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $56.03 | - | 43 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $340 | $360.54 | -5.70% | 38 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $20.46 | +71.07% | 48 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $164.28 | -26.95% | 81 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.27 | - | 1 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.49 | n/a | 1 | Jun 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $5.09 | n/a | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $34.87 | n/a | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $36.45 | n/a | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $10.23 | n/a | 1 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $20.59 | n/a | 1 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $0.0004 | n/a | 9 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $0.0001 | n/a | 7 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $20.46 | n/a | 1 | Oct 20, 2014 |
Guardant Health
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $127.34
Upside: -
Alamar Biosciences
May 12, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $20.06
Upside: +74.48%
Twist Bioscience
May 5, 2026
Upgraded: Buy
Price Target: $35 → $70
Current: $84.95
Upside: -17.60%
NeoGenomics
Apr 29, 2026
Upgraded: Buy
Price Target: $14 → $25
Current: $10.49
Upside: +138.32%
Thermo Fisher Scientific
Oct 23, 2025
Reiterated: Buy
Price Target: $500 → $580
Current: $472.63
Upside: +22.72%
Danaher
Oct 22, 2025
Reiterated: Buy
Price Target: $235
Current: $181.35
Upside: +29.58%
Revvity
Sep 16, 2025
Maintained: Buy
Price Target: $115 → $110
Current: $101.22
Upside: +8.67%
Repligen
Sep 11, 2025
Maintained: Buy
Price Target: $200
Current: $131.69
Upside: +51.87%
Quanterix
Sep 10, 2025
Maintained: Hold
Price Target: $6
Current: $3.06
Upside: +96.08%
Bruker
Sep 7, 2025
Maintained: Buy
Price Target: n/a
Current: $55.80
Upside: -
Sep 1, 2025
Maintained: Buy
Price Target: $140
Current: $128.34
Upside: +9.09%
Aug 18, 2025
Maintained: Buy
Price Target: n/a
Current: $220.11
Upside: -
Aug 11, 2025
Maintained: Hold
Price Target: $16
Current: $31.75
Upside: -49.61%
Aug 7, 2025
Maintained: Buy
Price Target: $45
Current: $50.92
Upside: -11.63%
Aug 7, 2025
Reiterated: Buy
Price Target: $10
Current: $2.02
Upside: +395.05%
Aug 6, 2025
Maintained: Hold
Price Target: $9
Current: $4.25
Upside: +112.01%
Aug 6, 2025
Upgraded: Buy
Price Target: $10 → $16
Current: $14.71
Upside: +8.77%
Aug 6, 2025
Upgraded: Buy
Price Target: $7 → $12
Current: $8.64
Upside: +38.89%
Aug 5, 2025
Maintained: Buy
Price Target: n/a
Current: $56.03
Upside: -
Aug 5, 2025
Reiterated: Buy
Price Target: $340
Current: $360.54
Upside: -5.70%
Aug 5, 2025
Maintained: Buy
Price Target: $35
Current: $20.46
Upside: +71.07%
Aug 1, 2025
Reiterated: Buy
Price Target: $120
Current: $164.28
Upside: -26.95%
Jul 29, 2025
Maintained: Buy
Price Target: n/a
Current: $4.27
Upside: -
Jun 1, 2025
Maintained: Buy
Price Target: n/a
Current: $2.49
Upside: n/a
May 9, 2025
Maintained: Buy
Price Target: $5
Current: $5.09
Upside: n/a
May 7, 2024
Maintained: Buy
Price Target: n/a
Current: $34.87
Upside: n/a
Dec 19, 2023
Maintained: Buy
Price Target: n/a
Current: $36.45
Upside: n/a
Jun 13, 2023
Maintained: Hold
Price Target: n/a
Current: $10.23
Upside: n/a
Apr 29, 2022
Maintained: Buy
Price Target: $16
Current: $20.59
Upside: n/a
Aug 24, 2021
Maintained: Buy
Price Target: $3
Current: $0.0004
Upside: n/a
Aug 24, 2021
Maintained: Buy
Price Target: $10
Current: $0.0001
Upside: n/a
Oct 20, 2014
Reiterated: Buy
Price Target: $80
Current: $20.46
Upside: n/a